HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2018 Issues

Cover

Vol. 20 • No. N1 • February 2018

In this issue:

  • Treatment Expansion for Opioid Use Disorders in the United States
    Parrino M.
  • Capgras Syndrome in a Heroin Addict. A Case Study
    Lovrecic M., and Lovrecic B.
  • Opioid Maintenance Therapy with Methadone and Levomethadone - Sexual Dysfunction and Treatment Satisfaction
    Schoofs N., Häbel T.H., Bermpohl F., and Gutwinski S.
  • On the Long-Term Status of Treatment-Seeking, Heroin Addicted Patients: A 22-Year Follow-up Study on Mortality and Drug Use in Portugal
    Pombo S., and Félix da Costa N.
  • Methadone Versus Torture: The Perspective of the European Court of Human Rights
    Junod V., Wolff H., Scholten W., Novet B., Greifinger R., Dickson C., and Simon O.
  • Characteristics of Methadone-Related Overdose Deaths and Comparisons between Those Dying on and Off Opioid Agonist Treatment (OAT):  a National Cohort Study.
    Van Hout M.C., Crowley D., Collins C., Barry A., Lyons S., and Delargy I.

 

Cover

Vol. 20 • No. N2 • April 2018

In this issue:

  • Methadone Dose as a Determinant of Infant Outcome During the Peri and Postnatal Period
    Wang M., Stapleton J., and Wolff K.
  • Affective Temperaments in Non-Depressed Patients with Alcohol and Opiate Addictions. Is  the “Dark Side” Associated with Current Depressive Symptoms?
    Kałwa A., Siwy-Hudowska A., and Niznikiewicz M.
  • Heroin Deaths in Norway in 2000 and 2009: A Comparative Study of Polydrug Use
    Karinen R., Konstantinova-Larsen S., Normann P.T., Mørland J., Christophersen A.S., and Arnestad M.
  • Refractory Bipolar Patient Treated with Oral Methadone: Does Methadone Act as Mood Stabilizer?
    Etaee F., Shirdel S., Azarhomayoun A., Nasiri K., and Komaki A.
  • Excess Suicide Mortality in Heroin Use Disorder Patients Seeking Opioid Agonist Treatment in Slovenia and Risk Factors for Suicide
    Lovrecic M., Lovrecic B., Maremmani I., and Maremmani A.G.I.
  • How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 5:  Higher Dosage
    Ulmer A., and Meinhold C.

 

Cover

Vol. 20 • No. NS1 • May 2018

In this issue:

Abstract book - 13th European Congress of European Opiate Addiction Treatment Association - EUROPAD - Krakow, Poland, May 25-27, 2018

 

Cover

Vol. 20 • No. N3 • June 2018

In this issue:

  • The Second to Fourth Digit (2d:4d) Ratios in Patients with Heroin Use Disorder
    Canan F., Sogucak S., Karaca S., Tegin C., Gecici O., and Kuloglu M.
  • Novel Psychoactive Synthetic Cannabinoids and Synthetic Cathinones: The Never-Ending Story of Potential Clinical Toxicity
    Lovrecic B., and Lovrecic M.
  • Relationship between Self-Mutilative Behaviour and Novelty Seeking, the Presence of Antisocial and Borderline Personality Disorders, and Severity of Psychopathology in a Sample of Male Patients with Heroin Use Disorder
    Evren C., Karabulut V., Alniak I., Umut G., Cetin T., Evren B., and Agachanli R.
  • Impact of Employment and Marital Status on Lapse Risk Situations among Addicted Patients in Methadone Maintenance Treatment
    Abed M.
  • How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting
    Staub L., Gerber M., Vogel M., Dürsteler-Macfarland K., Strom J., Schoen S., Pühse U., and Colledge F.
  • Diversion of Buprenorphine: Scope of the Problem and the Measures Taken to Address It
    Tripathi R., and Sarkar S.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Fax: 0584-72081 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page